Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Ghamande, Sharad A.

Augusta University
United States

Georgia CaRes 3UG1CA189851-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Molecular prediction of myeloma in African Americans 5U01CA271492-04 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.
Ghobrial, Irene M.

Dana-Farber Cancer Inst
United States

Myeloma multidimensional precancer atlas 4U01CA294507-02 Nicholas Hodges, Ph.D.
Ghosh, Jayashri

Temple Univ Of The Commonwealth
United States

Development of blood-based methylation biomarkers for CRC risk prediction 5R01CA281948-03 Matthew Young, Ph.D.
Giles, Erin

University Of Michigan At Ann Arbor
United States

Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause? 5R01CA269726-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Gill, Brian John Andrew

Columbia University Health Sciences
United States

The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma 1R01NS140658-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Godwin, Andrew K.

University Of Kansas Medical Center
United States

Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 5R01CA260132-05 Matthew Young, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma 1U01CA296639-01A1 Claire Zhu, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosomal biomarkers for the early detection of hepatocellular carcinoma 5R01CA271443-03 Matthew Young, Ph.D.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 3U01CA214254-08S2 Matthew Young, Ph.D.